FDA approves Tremfya for active Crohn's disease in adults
The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for adult patients with moderately to severely active Crohn disease.
Mar 25, 2025
0
20
MeSH tree: C06.405.469.432
The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for adult patients with moderately to severely active Crohn disease.
Mar 25, 2025
0
20
A recent study has revealed how Epstein-Barr virus (EBV) intensifies ulcerative colitis (UC), a debilitating inflammatory bowel disease. Researchers discovered that EBV infection triggers macrophage pyroptosis—a form of inflammatory ...
Mar 24, 2025
0
27
After every meal, the intestines perform an action called peristalsis—moving food through their hollow interiors with coordinated contractions and relaxations of the smooth muscle.
Mar 24, 2025
0
99
Almost half of people who died with inflammatory bowel disease (IBD) died prematurely, according to a study published in the Canadian Medical Association Journal that used machine learning models to predict death.
Mar 24, 2025
0
18
A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease, according to findings published in Science Immunology. The researchers said their discovery provides ...
Mar 21, 2025
0
104
One in three Australians with inflammatory bowel disease (IBD) left their medical consultations with misunderstandings about what was discussed, posing risks to their safety and the management of their condition, according ...
Mar 20, 2025
0
11
Janus kinase (JAK) inhibitors are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis. Since their approval, the indications ...
Mar 17, 2025
0
20
Colon cancer is one of the most dangerous cancers affecting women today.
Mar 17, 2025
0
21
A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation. A study shows that the semi-synthetic bile acid NorUDCA inhibits in the intestine the formation ...
Mar 13, 2025
0
17
Patients struggling with hard-to-detect conditions, such as long COVID; or with symptoms whose causes modern medical testing has trouble pinning down, such as irritable bowel syndrome, can feel dismissed when a doctor says ...
Mar 10, 2025
0
21